0001104659-19-047352.txt : 20190826
0001104659-19-047352.hdr.sgml : 20190826
20190826214919
ACCESSION NUMBER: 0001104659-19-047352
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190822
FILED AS OF DATE: 20190826
DATE AS OF CHANGE: 20190826
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lavino Francesco Maria
CENTRAL INDEX KEY: 0001711517
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 191054167
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
a4.xml
4
X0306
4
2019-08-22
0
0001641640
Nabriva Therapeutics plc
NBRV
0001711517
Lavino Francesco Maria
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA
PA
19406
0
1
0
0
Chief Commercial Officer
Ordinary Shares
2019-08-22
4
P
0
4800
2.0375
A
15972
D
The reporting person's purchase of ordinary shares of Nabriva Therapeutics plc (the "Issuer") reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 4,800 shares, with the reporting person's sale of 3,797 ordinary shares at a price of $2.08 per share on August 21, 2019. The reporting person has agreed to pay to the Issuer $204, representing the full amount of the profit realized in connection with the short-swing transaction.
/s/ Robert Crotty, by power of attorney
2019-08-26